On February 26, 2013 FDA & Healthcare partner Andrew Ruskin presented on the Current and Possible Future Part B Reimbursement Landscape at ACI's 11th annual In-House Counsel and Pricing Executive Forum on Government Regulation of Prescription Drug Pricing.
This forum offered Advanced Strategies for Counsel and their Government Pricing Clients on Medicaid and Medicare Pricing and Reimbursement.